openPR Logo
Press release

Orthostatic Hypotension Market is projected to reach USD 1.95 billion by 2034

12-11-2025 12:23 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Orthostatic Hypotension

Orthostatic Hypotension

The global Orthostatic Hypotension (OH) Market was valued at USD 1.09 billion in 2024 and is projected to reach USD 1.95 billion by 2034, growing at a CAGR of 6.1% during 2025-2034. Growth is driven by an aging global population, increasing prevalence of neurodegenerative diseases, rising cases of autonomic dysfunction, improved diagnostic awareness, and growing adoption of pharmacologic and non-pharmacologic treatment options.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70956

Orthostatic hypotension is defined as a drop in systolic blood pressure less than 20 mmHg or diastolic less than 10 mmHg within three minutes of standing. It is commonly associated with neurogenic conditions such as Parkinson's disease, multiple system atrophy (MSA), and diabetic autonomic neuropathy, but can also occur due to dehydration, medications, or cardiovascular diseases. Symptoms include dizziness, fatigue, blurred vision, cognitive impairment, and increased fall risk-particularly in older adults.

Key Market Highlights
• 2024 Market Size: USD 1.09 billion
• 2034 Forecast: USD 1.95 billion
• CAGR (2025-2034): 6.1%
• Largest Segment: Pharmacologic therapy (midodrine, droxidopa)
• Fastest-Growing Segment: Advanced autonomic diagnostic technologies & wearable blood-pressure tools

Epidemiology & Clinical Insights
1. Global Prevalence
• Affects 5-20% of adults above 60 years.
• Prevalence is significantly higher in patients with:
o Parkinson's disease
o Diabetic neuropathy
o Multiple system atrophy
o Pure autonomic failure
2. Key Symptoms
• Lightheadedness
• Syncope
• Difficulty concentrating
• Fatigue & weakness
• Visual disturbances
• Falls and injuries
3. Diagnostic Tools
• Orthostatic blood pressure test
• Tilt-table testing
• Autonomic function tests
• ECG/Holter monitoring
• Blood volume and plasma norepinephrine assessment

Market Growth Drivers
1. Increasing Aging Population
Aging-associated autonomic dysfunction is one of the strongest drivers of new diagnoses.
2. Rise in Neurodegenerative Diseases
Growing prevalence of Parkinson's disease and MSA significantly increases neurogenic OH cases.
3. Improved Diagnostic Awareness
Clinicians increasingly screen for OH in elderly patients, diabetics, and those with autonomic neuropathy.
4. Expanding Therapeutic Options
Demand rising for:
• Midodrine (first-line vasoconstrictor)
• Droxidopa (norepinephrine precursor)
• Fludrocortisone (volume-expanding steroid)
• Pyridostigmine (enhances sympathetic tone)
5. Growth in Home Monitoring & Wearable Devices
Digital BP monitors and fall-risk detection sensors support long-term disease management.

Market Restraints
• Limited curative therapies - OH is typically chronic
• Underdiagnosis due to symptom overlap with other conditions
• Side effects of long-term medications (hypertension, headaches, tachycardia)
• Slow adoption of autonomic testing in low-income regions

Market Opportunities
1. Novel Therapeutics & Mechanisms
New vasoconstrictors, NE-enhancing molecules, and autonomic modulators.
2. Digital Health & Remote BP Monitoring
AI-driven BP trend prediction and fall-prevention analytics.
3. Increased Research in Neurogenic OH
Especially for Parkinson's, MSA, and diabetic autonomic neuropathy.
4. Wearables & Continuous BP Sensors
Non-invasive monitoring enables precision dosing and personalized therapy.
5. Geriatric Care Expansion
More geriatric clinics adopting orthostatic BP screening protocols.

Segmentation Overview
By Type
• Neurogenic Orthostatic Hypotension (nOH)
o Parkinson's disease
o Multiple system atrophy
o Pure autonomic failure
o Diabetic neuropathy
• Non-Neurogenic Orthostatic Hypotension
o Dehydration
o Cardiovascular issues
o Drug-induced (antihypertensives, antidepressants)

By Treatment
• Midodrine
• Droxidopa
• Fludrocortisone
• Pyridostigmine
• Compression garments
• Hydration/salt therapy
• Lifestyle and physiotherapy

By Diagnostic Tool
• Tilt-table test
• Orthostatic BP measurement
• Autonomic function testing
• Ambulatory BP monitoring
• Digital wearable sensors

By End User
• Hospitals & neurology clinics
• Cardiology centers
• Geriatric care centers
• Home-care & remote monitoring platforms

Explore Full Report here: https://exactitudeconsultancy.com/reports/70956/orthostatic-hypotension-market

Regional Insights
North America - Largest Market
High diagnosis rates, widespread awareness of neurogenic OH, and strong uptake of droxidopa.
Europe - Strong Growth
Germany, France, UK, Italy, and Spain lead screenings in neurology & geriatric clinics.
Asia Pacific - Fastest Growing
Rapid aging in Japan, China, and South Korea increases OH prevalence.
Latin America - Developing
Improved cardiovascular and neurology infrastructure drives moderate growth.
Middle East & Africa - Emerging
Rising prevalence of diabetes and cardiovascular disease boosts demand.

Competitive Landscape
Major companies active in the orthostatic hypotension therapeutics market include:
• Lundbeck (droxidopa)
• Shire/Takeda
• Amneal Pharmaceuticals
• Novartis
• Pfizer
• Teva Pharmaceuticals
• Mylan
• Bayer
• AbbVie
Companies are focusing on improving drug tolerability, expanding indications, and integrating digital BP monitoring solutions.

Recent Market Developments
• New clinical trials underway for improved autonomic modulators
• Expansion of droxidopa use in Parkinson's disease-related nOH
• AI-enabled wearable BP monitoring devices gaining FDA clearances
• Increased awareness campaigns targeting geriatric fall prevention
• Novel biomarkers for autonomic failure entering research phases

Future Outlook (2025-2034)
The orthostatic hypotension market is set for sustained growth as:
• Neurodegenerative disorders increase worldwide
• Wearable cardiovascular monitoring expands
• New therapeutics enter the pipeline
• Geriatric populations accelerate global demand
By 2034, the market is expected to reach USD 1.95 billion, with strong opportunities in neurogenic OH management and digital health integration.

This report is also available in the following languages : Japanese (起立性低血圧), Korean (기립성 저혈압), Chinese (直立性低血压), French (Hypotension orthostatique), German (Orthostatische Hypotonie), and Italian (Ipotensione ortostatica), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/70956

Our More Reports:

Funnel Chest Orthosis Market
https://exactitudeconsultancy.com/reports/55100/global-funnel-chest-orthosis-market

Ceramic Scintillator Materials Market
https://exactitudeconsultancy.com/reports/57510/global-ceramic-scintillator-materials-market

Tetraalkoxysilane Market
https://exactitudeconsultancy.com/reports/60815/global-tetraalkoxysilane-market

Electronic Grade Tetraethyl Orthosilicate (TEOS) Market
https://exactitudeconsultancy.com/reports/61312/global-electronic-grade-tetraethyl-orthosilicate-teos-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Orthostatic Hypotension Market is projected to reach USD 1.95 billion by 2034 here

News-ID: 4311636 • Views:

More Releases from Exactitude Consultancy

Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitation and Infrastructure Projects
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250 Key Market Highlights • Increasing focus on road maintenance and resurfacing projects • Growing demand for efficient and precision milling
Credit Management Software Market Accelerates as Organizations Focus on Risk Mitigation and Cash Flow Optimization
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248 Key Market Highlights • Growing adoption of automated credit risk assessment tools • Increasing focus on working capital and cash flow management • Integration
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Operators Strengthen Network Security
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246 Key Market Highlights • Growing adoption of VoIP and
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Traction Amid Global Decarbonization Efforts
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244 Key Market Highlights • Rapid growth of

All 5 Releases


More Releases for Orthostatic

Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Research Repor …
Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. View Sample Report https://reports.valuates.com/request/sample/QYRE-Auto-29X6020/Global_Postural_Orthostatic_Tachycardia_Syndrome_POTS_Treatment_Market_Insights_Forecast_to_2028 Report Scope The diagnosis of Postural Orthostatic Tachycardia Syndrome (POTS) has significantly increased due to advances in medical research and increased awareness among healthcare practitioners. There is now a greater need for treatment choices as a result of the condition's improved identification
Global Orthostatic Hypotension Market Research Report 2023-2029
Orthostatic hypotension, also known as postural hypotension, is a state of dizziness that is caused due to low blood pressure. This is commonly happen when a person stands up from a long sitting and feel dizziness. Orthostatic hypotension can be caused due to heart problems, dehydration, endocrine problems and nervous system disorders. Global Orthostatic Hypotension Market: Driven factors and Restrictions factors The research report encompasses a comprehensive analysis of the factors that
Latest Trends in Global Orthostatic Hypotension Drugs Market
A report added to the rich database of Zion Market Research, "Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) - Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025", provides a 360-degree overview of the worldwide market. The Orthostatic Hypotension Drugs Market report aims to provide
Orthostatic Hypotension Drugs Market to Witness Robust Expansion by 2024
LP INFORMATION offers a latest published report on Orthostatic Hypotension Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Orthostatic Hypotension Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.
Orthostatic Hypotension Drugs Market to Witness Robust Expansion by 2025
Market Research Report Store offers a latest published report on Orthostatic Hypotension Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Orthostatic Hypotension Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Orthostatic Hypotension Drugs with respect
Orthostatic Hypotension Market to Record an Impressive Growth Rate By 2022
Orthostatic hypotension, also known as postural hypotension, is a state of dizziness that is caused due to low blood pressure. This is commonly happen when a person stands up from a long sitting and feel dizziness. Orthostatic hypotension can be caused due to heart problems, dehydration, endocrine problems and nervous system disorders. Also, it has been found that nursing home elderly residents are more prone to OH than people who